Select your language close

Spyros Batzios 医生

Consultant in Paediatric Metabolic Medicine

概述

Dr Batzios graduated from the Medical School of the Aristotle University of Thessaloniki in Greece in 2005 and has continued on a Postgraduate level by completing a 2 year MSc program in ‘‘Medical Research Methodology’’ with a special interest in Basic Research.

Dr Batzios' PhD thesis was related to the ‘‘Study of the expression of extracellular matrix molecules in patients with Mucopolysaccharidoses and Neurofibromatosis type I’’. Dr Batzios has finished the training in General Paediatrics in a busy tertiary University Hospital in Greece and awarded my CCT with the highest score among all participants. 

Dr Batzios has worked as a Consultant in Paediatric Metabolic Medicine in GOSH in London for 5 years.

使用语言:

  • Greek
  • French (Basic)

相关资质

  • General Metabolic
  • Neurometabolic disorders
  • LYSOSOMAL Storage Disorders
  • Hyperlipidaemias and Familial Hypercholesterolaemia
  • Hypoglycaemia
  • General Metabolic
  • Neurometabolic disorders
  • LYSOSOMAL Storage Disorders
  • Hyperlipidaemias and Familial Hypercholesterolaemia
  • Hypoglycaemia

 

 

01/2016: Completion of training in Paediatric Metabolic Medicine

12/2013: Certified as a General Paediatrician after Board examination, GPA:8/10 (highest score among participants)

Qualifications:

05/2010 – 06/2015: Postgraduate studies program (PhD diploma 2015. GPA: 10/10 with distinction)

09/2007 – 06/2009: Postgraduate studies program (MSc degree diploma 2009. GPA: 9.77/10)

09/1999 – 09/2005: Medical doctor (Medicine diploma 2005. GPA: 7/10)

Memberships:

Member of the BIMDG and SSIEM societies (2013 - onwards)

Board member of the Hellenic Society for the Study of Inborn Errors of Metabolism since (12/2012 - onwards)

Dr Batzios's MSc and PhD were related to the study of extracellular matrix molecules in patients with Mucopolysaccharidoses and other Lysosomal Storage Disorders.

  • General Metabolic
  • Neurometabolic disorders
  • Lysosomal Storage Disorders
  • Hyperlipidaemias and Familial Hypercholesterolaemia
  • Hypoglycaemia

 

新闻和论文发表

Role of Intramuscular Levofolinate Administration in the Treatment of Hereditary Folate Malabsorption: Report of Three Cases. Manea E, Gissen P, Pope S, Heales SJ, Batzios S. JIMD Rep. 2017 Jul 7. doi: 10.1007/8904_2017_39.

Neuroradiological, neurophysiological and molecular findings in infantile Krabbe disease: two case reports. Vargiami E, Papathanasiou E, Batzios S, Kyriazi M, Dimitriou E, Anastasiou A, Michelakakis H, Giese AK, Zafeiriou DI. Balkan J Med Genet. 2016

Nephrocalcinosis and Renal Failure in Lesch-Nyhan Syndrome: Report of Two Familial Cases and Review of the Literature. Vargiami E, Printza N, Papadimiditriou E, Batzios S, Kyriazi M, Papachristou F, Zafeiriou DI.Urology. 2016

Extracellular matrix components: an intricate network of possible biomarkers for lysosomal storage disorders? Batzios SP, Zafeiriou DI, Papakonstantinou E. FEBS Lett 2013;587(8):1258-67.

Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes. Symeonidis C, Papakonstantinou E, Galli A, Tsinopoulos I, Mataftsi A, Batzios S, Dimitrakos SA. Graefes Arch Clin Exp Ophthalmol 2013;251(3):741-9.

Brain and spinal MRI findings in Mucopolysaccharidoses: a review. Zafeiriou DI, Batzios SPAJNR Am J Neuroradiol 2013

Differential expression of matrix metalloproteinases in the serum of patients with mucopolysaccharidosesBatzios SP, Zafeiriou DI, Vargiami E, Karakiulakis G, Papakonstantinou E. JIMD Rep 2012

Developing treatment options for metachromatic leukodystrophy. Batzios SP, Zafeiriou DI. Mol Genet Metab 2012

 

 

Spyros Batzios 医生详情

与他人分享Spyros Batzios 医生的履历